Leptivia®

Home Leptivia

Leptivia®

INDICATION: Obesity

Leptivia® is a new safe anti-obesity drug product repurposed from existing safe drug molecule.

Discover Leptivia®

drug-overview
Overview

Leptivia® is designed to provide weight loss through satiety and appetite suppression.

Phase

Leptivia® CR is currently in Phase I clinical trial.

US Market ($B USD)

The estimated market for Leptivia® in the United States is $0.85 Billion USD.

Global Market ($B USD)

The estimated market for Leptivia® globally is $1.2 Billion USD.

Inquire About Leptivia®